Subscribe
sanofi
Monticello / Shutterstock
6 June 2023FeaturesBig PharmaMuireann Bolger

Sanofi v Amgen antibody case lands front of queue at UPC

The  Unified Patent Court (UPC) may be less than a week old but it is already set to be the latest stage for the long-running dispute between Sanofi and Amgen concerning antibody patents.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
UPC: life sciences lead the momentum at new court
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
UPC announces hearing details for Edwards Lifesciences
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
UPC: life sciences lead the momentum at new court
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
UPC announces hearing details for Edwards Lifesciences
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.

More on this story

Big Pharma
UPC: life sciences lead the momentum at new court
15 August 2023   Are we now seeing the power posed by the court as a litigation forum, asks Antje Brambrink of Finnegan.
Big Pharma
UPC confirms dates for 10x Genomics hearings
22 August 2023   UPC announces public hearings at Munich court | Proceedings relate to the dispute over patents covering the in-situ detection of analytes.
Big Pharma
UPC announces hearing details for Edwards Lifesciences
31 August 2023   Edwards Lifesciences files application for provisional measures at UPC | Hearing details adds to existing listed by the court for 10x Genomics versus NanoString.

More features

UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
GSK triumphs in EPO appeal, revoking Pfizer patent
Herbert Smith Freehills and Kramer Levin in $2bn merger talks
Teva fights for re-listing of inhaler patents at US appeals court
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m